111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-71.04%
Gross profit decline while CX shows 19.25% growth. Joel Greenblatt would examine competitive position.
-71.04%
Margin decline while CX shows 2.64% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-96.01%
EBITDA decline while CX shows 8.00% growth. Joel Greenblatt would examine position.
-96.01%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-95.63%
Operating income decline while CX shows 29.76% growth. Joel Greenblatt would examine position.
-95.63%
Operating margin decline while CX shows 11.69% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
136.11%
Tax expense growth less than half of CX's 346.15%. David Dodd would verify if advantage is sustainable.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.04%
Share count reduction while CX shows 1.64% change. Joel Greenblatt would examine strategy.
-0.05%
Diluted share reduction while CX shows 1.64% change. Joel Greenblatt would examine strategy.